Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuji Inoue

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|June 25, 2005
TRP channels as a newly emerging non-voltage-gated CA2+ entry channel superfamilyRyuji Inoue
Novartis Foundation Symposium|August 8, 2002
Molecular candidates for capacitative and non-capacitative Ca2+ entry in smooth muscleRyuji Inoue, Yasuo Mori
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
New target molecules in the drug control of blood pressure and circulationRyuji Inoue, Yasuo Mori
British Journal of Pharmacology|July 22, 2014
TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cellsJun Ichikawa, Ryuji Inoue
Journal of Pharmacological Sciences|November 5, 2014
New experimental trends for phosphoinositides research on ion transporter/channel regulationMasayuki X Mori, Ryuji Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[The TRP proteins, a rapidly expanding Ca2+ entry channel family and a new molecular target for drug development]Ryuji Inoue, Yushi Ito, Yasuo Mori
Seminars in Immunopathology|October 21, 2015
"TRP inflammation" relationship in cardiovascular systemTomohiro Numata, Kiriko Takahashi, Ryuji Inoue
Expert Opinion on Therapeutic Targets|July 23, 2004
Newly emerging Ca2+ entry channel molecules that regulate the vascular toneRyuji Inoue, Hiromitsu Morita, Yushi Ito
Current Opinion in Nephrology and Hypertension|February 16, 2008
Pathophysiological implications of transient receptor potential channels in vascular functionRyuji Inoue, Lin Hai, Akira Honda
Pharmacology & Therapeutics|June 9, 2009
Mechanosensitive TRP channels in cardiovascular pathophysiologyRyuji Inoue, Zhong Jian, Yasuhiro Kawarabayashi
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|June 25, 2005
TRP channels as a newly emerging non-voltage-gated CA2+ entry channel superfamilyRyuji Inoue
Novartis Foundation Symposium|August 8, 2002
Molecular candidates for capacitative and non-capacitative Ca2+ entry in smooth muscleRyuji Inoue, Yasuo Mori
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
New target molecules in the drug control of blood pressure and circulationRyuji Inoue, Yasuo Mori
British Journal of Pharmacology|July 22, 2014
TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cellsJun Ichikawa, Ryuji Inoue
Journal of Pharmacological Sciences|November 5, 2014
New experimental trends for phosphoinositides research on ion transporter/channel regulationMasayuki X Mori, Ryuji Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[The TRP proteins, a rapidly expanding Ca2+ entry channel family and a new molecular target for drug development]Ryuji Inoue, Yushi Ito, Yasuo Mori
Seminars in Immunopathology|October 21, 2015
"TRP inflammation" relationship in cardiovascular systemTomohiro Numata, Kiriko Takahashi, Ryuji Inoue
Expert Opinion on Therapeutic Targets|July 23, 2004
Newly emerging Ca2+ entry channel molecules that regulate the vascular toneRyuji Inoue, Hiromitsu Morita, Yushi Ito
Current Opinion in Nephrology and Hypertension|February 16, 2008
Pathophysiological implications of transient receptor potential channels in vascular functionRyuji Inoue, Lin Hai, Akira Honda
Pharmacology & Therapeutics|June 9, 2009
Mechanosensitive TRP channels in cardiovascular pathophysiologyRyuji Inoue, Zhong Jian, Yasuhiro Kawarabayashi
Pageof 9